Frank V. Fossella
Papers
1
Total Citations
28
H-Index
1
About
Frank V. Fossella is a leading thoracic oncologist whose research has fundamentally shaped the treatment of non-small cell lung cancer (NSCLC), particularly through the integration of immunotherapy into perioperative care. His work focuses on optimizing neoadjuvant and adjuvant strategies, with a major contribution being the landmark NEOSTAR study. This pivotal trial investigated surgical outcomes following neoadjuvant nivolumab alone or in combination with ipilimumab, demonstrating that dual immunotherapy significantly improves pathologic complete response rates—a finding that has directly influenced clinical guidelines and practice. With over 28 citations on this key paper alone, Fossella’s research has helped shift the paradigm toward immunotherapy-based approaches before surgery, offering patients better chances for long-term survival. Beyond NEOSTAR, his extensive portfolio includes pioneering work on targeted therapies and chemotherapy regimens for advanced NSCLC. A dedicated clinician-scientist at the University of Texas MD Anderson Cancer Center, Fossella has authored numerous high-impact studies that continue to guide how oncologists combine surgery and immunotherapy. His contributions remain essential reading for any researcher or student exploring the evolving landscape of lung cancer treatment.
Research Focus
Key Achievements
Top Papers
- 1